Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

MESOBLAST LTD (MESO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Final Director’s Interest Notice, Michael Spooner",
"Final Director’s Interest Notice, Michael Spooner"
07/31/2023 6-K Quarterly results
07/31/2023 6-K Quarterly results
07/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"ABN 68 109 431 870 1.3",
"Appendix 3H of Mesoblast Ltd",
"Appendix 3Y of Mesoblast Ltd",
"Appendix 3Y of Mesoblast Ltd"
06/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Appendix 3Y of Mesoblast Ltd",
"Appendix 3Y of Mesoblast Ltd"
05/26/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"MESOBLAST REPORTS OPERATIONAL AND FINANCIAL HIGHLIGHTS FOR QUARTER ENDED MARCH 31, 2023",
"Investor presentation of Mesoblast Ltd"
05/03/2023 6-K Quarterly results
03/22/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"FDA SCHEDULES PRE-LICENSE INSPECTION OF REMESTEMCEL-L MANUFACTURING"
02/21/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"REMESTEMCEL-L CLINICAL AND POTENCY STUDIES PRESENTED AT PREMIER MEETING OF TRANSPLANTATION RESEARCH AND THERAPY"
02/01/2023 6-K Quarterly results
12/28/2022 6-K Quarterly results
12/07/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Appendix 3G of Mesoblast Ltd",
"Appendix 3H of Mesoblast Ltd",
"Appendix 3Y of Mesoblast Ltd"
11/28/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"CHILDREN TREATED WITH REMESTEMCEL-L SHOW LONG-TERM SURVIVAL THROUGH FOUR YEARS IN STEROID-REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE",
"MESOBLAST REPORTS FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS FOR THE PERIOD ENDED SEPTEMBER 30, 2022",
"Presentation to Annual General Meeting",
"Chairman’s Annual General Meeting address",
"Results of Annual General Meeting"
11/28/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
11/16/2022 6-K Quarterly results
11/07/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Corporate Governance Statement and Appendix 4G of Mesoblast Ltd",
"Notice of Annual General Meeting of Mesoblast Ltd",
"Appendix 4C of Mesoblast Ltd"
10/04/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"MESOBLAST SUBMITS NEW INFORMATION TO FDA IND FILE IN RESPONSE TO ITEMS IN THE CRL TO THE REMESTEMCEL-L BLA FOR SR-aGVHD"
09/23/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Appendix 3Y of Mesoblast Ltd",
"Appendix 3Y of Mesoblast Ltd"
09/14/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Appendix 3Y of Mesoblast Ltd",
"Appendix 3Y of Mesoblast Ltd"
08/31/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"MESOBLAST REPORTS FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS FOR FISCAL YEAR ENDED JUNE 30, 2022",
"Investor presentation of Mesoblast Ltd"
08/16/2022 6-K Quarterly results
08/05/2022 6-K Quarterly results
07/20/2022 6-K Quarterly results
07/14/2022 6-K Quarterly results
06/17/2022 6-K Quarterly results
06/03/2022 6-K Quarterly results
06/02/2022 6-K Quarterly results
05/23/2022 6-K Quarterly results
05/02/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Appendix 4C of Mesoblast Ltd",
"Appendix 4C of Mesoblast Ltd"
04/20/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Appendix 3H of Mesoblast Ltd",
"Appendix 3G of Mesoblast Ltd"
04/11/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"APPOINTMENT OF JOINT COMPANY SECRETARY"
03/30/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"PHILIP R. KRAUSE, M.D., FORMER FDA DEPUTY CHIEF FOR VACCINES, JOINS MESOBLAST BOARD",
"Initial Director’s Interest Notice, Philip R. Krause"
02/28/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Final Director’s Interest Notice, Donal O’Dwyer",
"Final Director’s Interest Notice, Donal O’Dwyer"
02/25/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"OPERATIONAL HIGHLIGHTS AND FINANCIAL RESULTS FOR THE PERIOD ENDED DECEMBER 31, 2021",
"Investor presentation of Mesoblast Ltd"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy